The Massey Cancer Center will continue the research programs that currently exist with some possible modifications. We are also exploring whether there is a critical mass of funded investigators that are active in the area of """"""""Carcinogenesis,"""""""" with the possibility that a new basic research program area may be formed involving some newly recruited faculty members to Centers program as well as new arrivals to our institution. The major thrust for new development for the next grant year is in the broad discipline of """"""""Immunology."""""""" This will involve an active recruitment of a faculty member in """"""""Tumor Immunology,"""""""" (using Developmental Funds) to complement the core of investigators in this area that are currently active and quite productive. Moreover, the basic research in immunology will contribute to and be enhanced by the planned recruitment of a clinical bone marrow transplantation scientist-clinician. This individual will lead the development of this clinical service activity for both pediatric and adult patients needs, as well as the clinical research related to it. Due to the completion of our clinical facility development project for both in-patient and out-patient areas expected in the spring of 1986, we will have new and expanded space for the Joint Cancer Clinic, as well as for the Medical-Surgical Oncology in-patient unit. The latter space will include new laminar flow rooms to be devoted to the development of the bone marrow transplantation program. Influential members of our Virginia community have become involved in a private fund raising plan for the financial support for this ambitious new program. The Cancer Education Program has been expanded in our center to include nursing oncology education as well as the medical and dental programs that have been on-going for many years. This program has a heavy emphasis on cancer research by the students of these schools and will draw upon and contribute to the established research programs of the Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-11
Application #
3101535
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1978-12-01
Project End
1987-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
11
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Overall Medical
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Wu, Xiaowei; Guan, Ting; Liu, Dajiang J et al. (2018) ADAPTIVE-WEIGHT BURDEN TEST FOR ASSOCIATIONS BETWEEN QUANTITATIVE TRAITS AND GENOTYPE DATA WITH COMPLEX CORRELATIONS. Ann Appl Stat 12:1558-1582
Chawla, Ayesha T; Cororaton, Agnes D; Idowu, Michael O et al. (2018) An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition. Oncotarget 9:32408-32418
Zarate-Perez, Francisco; Velázquez-Fernández, Jesús B; Jennings, Gareth K et al. (2018) Biophysical characterization of Aptenodytes forsteri cytochrome P450 aromatase. J Inorg Biochem 184:79-87
Montefusco, David J; Allegood, Jeremy C; Spiegel, Sarah et al. (2018) Non-alcoholic fatty liver disease: Insights from sphingolipidomics. Biochem Biophys Res Commun 504:608-616
Yamada, Akimitsu; Nagahashi, Masayuki; Aoyagi, Tomoyoshi et al. (2018) ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. Mol Cancer Res 16:1059-1070
Cantwell, Marc T; Farrar, Jared S; Lownik, Joseph C et al. (2018) STAT3 suppresses Wnt/?-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine 111:434-444
Aqbi, Hussein F; Wallace, Matthew; Sappal, Samay et al. (2018) IFN-? orchestrates tumor elimination, tumor dormancy, tumor escape, and progression. J Leukoc Biol :
Volker, Sonja E; Hedrick, Shannon E; Feeney, Yvonne B et al. (2018) Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland. Cancer Res 78:3877-3887
Li, Xiaojiaoyang; Liu, Runping; Huang, Zhiming et al. (2018) Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68:599-615
Durant, Stephen T; Zheng, Li; Wang, Yingchun et al. (2018) The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv 4:eaat1719

Showing the most recent 10 out of 586 publications